Amorphical is a pioneering Israeli pharmaceutical company developing and manufacturing a unique form of calcium called amorphous calcium carbonate (ACC). We believe these new calcium-based therapeutics can become effective new tools for treating osteoporosis, hypoparathyroidism and a range of other calcium-related diseases.
Inspired by the ability of the Australian Blue Crayfish to shed and regrow its exoskeleton in only three days, Amorphical scientists have demonstrated ACC’s safety, efficacy and high bioavailability, and were able to develop a proprietary synthetic form of ACC.
DENSITY, Amorphical’s first ACC-based supplement, was approved for over-the-counter sale and distribution by Israel’s Ministry of Health in May 2014 and by Hong Kong’s Centre of Food Safety in May 2014. Already thousands of people are using DENSITY as an everyday calcium supplement.
The company’s R&D pipeline continues to expand and includes a variety of pharmaceutical applications, including osteoporosis, hypoparathyroidism, and cancer-related bone metastases.
To purchase DENSITY, the new generation of calcium, please click here.